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Background
miRNAs are short 21-24 nt RNAs that mediate post tran-
scriptional repression of target genes. Various reports have
shown that miRNAs are capable of repressing the gene
expression levels of different viruses, leading to the sug-
gestion that miRNAs are key mediators of host-virus inter-
action [1]. HIV-1 is a retrovirus known to cause AIDS, one
of the major diseases in humans. The nef gene of the HIV-
1 has been shown to be important for virus repression of
CD4+ cells and virus progression. It has also been shown
earlier that patients infected with nef deleted HIV-1 do not
progress from infected to diseased state for longer periods
of time, resulting in the Long Term Non-Progressor phe-
notype [2].
Materials and methods
We computationally predicted five endogenously
expressed human miRNAs to target the nef gene of HIV-1
retrovirus. On applying other stringency parameters we
could focus on two of the five miRNAs viz. hsa-mir-29a
and hsa-mir-29b as they were predicted to target the nef
gene, at sites highly conserved amongst other clades of
HIV-1 [3].
We then created reporter carrying the nef gene inserted
downstream of a luciferase reporter. miRNA expression
vectors were also made which would express the pri-
miRNA when processed and thereby lead to high levels of
the miRNA inside the cells. We then identified various cell
lines for validating nef as a target for hsa-mir-29a and hsa-
mir-29b.
Results and discussion
Gene reporter assays and ectopic over-expression of miR-
NAs conclusively showed that human cellular miRNAs
hsa-mir-29a and hsa-mir-29b could bring down the nef
protein levels and also affect viral replication [4]. These
results would provide a better understanding of the mech-
anisms that could regulate the viral gene expression and
human cellular antiviral defense mechanisms whereby
miRNAs could serve as potential therapeutics to treat var-
ious viral diseases.
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